CSF2 and neoplasm: The strong induction of GM-CSF production by CC-5013 in all nine patients is further evidence of immune activation and is likely to lead to the stimulation and increased functional capacity of monocytes/macrophages and dendritic cells (Armitage, 1998), thereby potentially boosting the presentation of tumour antigens.